Leptospirosis Presentation

  • Upload
    kay-ruz

  • View
    225

  • Download
    0

Embed Size (px)

Citation preview

  • 8/12/2019 Leptospirosis Presentation

    1/16

    Differences between AKURIT and

    conventional TB drugs.AKURIT is one of the fixed dose combinations for anti TB medications.The 2 FDCs available in MOH Drug formulary for adult are:

    4drugs combination : INH 75mg, RIF 150mg, PZA 400mg and EMB

    275mg

    3 drug combination : INH 75mg, RIF 150mg, PZA 400mg

    The recommended dosage for the 2 FDC are

    30 - 37 kg body weight: 2 tablets daily

    38 - 54 kg body weight: 3 tablets daily

    55 - 70 kg body weight: 4 tablets daily

    More than 70 kg body weight: 5 tablets daily

    FDC help reducing the emergence of drug resistance TB and reduce pillburdens for patient and increase patient adherence to medication.

    The conventional TB drugs is the separation of anti TB drugs and its normally

    used if patients developed drug toxicity, intolerance or contraindications to its

    component.

  • 8/12/2019 Leptospirosis Presentation

    2/16

    Treatment and prophylaxis for PCPPCP prophylaxisOne double strength of cotrimoxazole daily or dapsone 100mg daily if

    cotrimoxazole is contraindicated.

    The duration of prophylaxis is until the CD4 count > 200 for 3 months

    PCP treatment

    Trimetoprim 15-20mg/kg /day plus sulfamethoxazaole 75-100mg/kg/day in

    QID or TDS

    Treatment duration is 21 days.

    National antibiotic guideline 2008 & the National Institutes of Health, and the HIV

    Medicine Association of the Infectious Diseases Society of America.

  • 8/12/2019 Leptospirosis Presentation

    3/16

    Treatment duration for syphilisTreatment of primary and secondary syphilis among HIV infected patients in

    benzathine penicilline G, 2.4 mu intramuscular in a single dose.

    Most HIV positive pateints who have early syphilis might be at risk for

    neurologic complications. Based on the national antibiotic guideline 2008,

    patients infected with HIV with syphilis should be treated as neurospiphylis.Benzylpenicillin 3-4 mu 4 hourly for 14 days.

  • 8/12/2019 Leptospirosis Presentation

    4/16

    Clinical

    Case PresentationHIV-TB co-infection

    By Khairuzzaman

  • 8/12/2019 Leptospirosis Presentation

    5/16

    Patient Details

    Name: Mr S

    RN: HTJ 476731

    Age: years old Race: Malay

    Gender: male

    DOA: 21/11/13 Weight: 95 kg

  • 8/12/2019 Leptospirosis Presentation

    6/16

    Chief complaint

    Fever and referred from private clinic

    History of Presenting Illness

    Fever for 2 days

    Arthralgia for 1 day

    Vomiting 2 times per day

    Low of apatite for 2 days Lives at dengue area

    Exposed to rat at home

  • 8/12/2019 Leptospirosis Presentation

    7/16

    Social History Chronic smoker

    History of alleged MVA in 1997, claimed laser done for

    blood clot

    Review of System

    BP 89/28

    PR 110

    Temp 39.8

    Spo2 100

  • 8/12/2019 Leptospirosis Presentation

    8/16

    Provisional Diagnosis

    1. Septic shock secondary pneumonia

    2. TRO dengue fever

    Diagnosis

    1. leptospirosis

  • 8/12/2019 Leptospirosis Presentation

    9/16

    Leptospirosis

    Causal agent: leptospira genus (longcorkscrew-shaped bacteria). It is too thin to be

    visible under ordinary microscope.

    Mode of transmission: domestic animal arethe reservoir of the agent and transmitted

    through contact with the urine membranous

    or broken skin with water or foodcontaminated with urine of the infected

    animals.

  • 8/12/2019 Leptospirosis Presentation

    10/16

  • 8/12/2019 Leptospirosis Presentation

    11/16

    Laboratory results:

    FBC Reference range 21/11 22/11

    TWBC 4-11x10/L 9.4 5.7

    HB 11.5-16.5

    g/100mL

    14.1 13.6

    Platelet 150-400 g/100mL 198 166

  • 8/12/2019 Leptospirosis Presentation

    12/16

    Renal

    profile

    Reference range 21/11 22/11 25/11

    Urea 1.7-8.3 mmol/L 3.7 2.1 5.6

    Na+

    135-145 mmol/L 132 134 126K+ 3.5-5.0 mmol/L 3.9 2.8 4.0

    SCr 64122 mmol/L 104 101 112

    CrCl 105-150 ml/min

    PO4- 0.8-1.45 mmol/L 0.5

    Ca2+ 2.12.6 mmol/L 2.07

    Liver profile Reference

    range

    21/11 22/11 25/11

    Albumin 35-50g/L 31 32 32

    T. Bilirubin

  • 8/12/2019 Leptospirosis Presentation

    13/16

    Ward medicationDrug Date

    start

    Date

    stop

    Indication

    IV CEFTRIAXONE 1G BD 21/11 21/11 Empirical therapy for CAP

    IV CEFTRIAXONE 2G OD 21/11 Empirical therapy for CAP

    T AZITHROMYCIN 500MG

    OD

    22/11 Empirical therapy for CAP

    T. PARACETAMOL 1G STAT 22/11 Antipyretic

    IV TRAMADOL 50MG STAT

    TDS

    23/11 Analgesic

    IV METOCHLORPRAMIDE

    10MG STAT

    23/11 Antiemetic

    IV OMEPRAZOLE 20MG BD 25/11 Gastritis

  • 8/12/2019 Leptospirosis Presentation

    14/16

    Pharmaceutical

    Care Issue

  • 8/12/2019 Leptospirosis Presentation

    15/16

  • 8/12/2019 Leptospirosis Presentation

    16/16

    Inappropriate drug management

    Patient was provisionally diagnosed with sepsis secondary to

    pneumonia and treated with IV ceftriaxone 2g od and T.

    azithromycin 500mg od. On 22/11 patient was confirmed with

    leptosirosis based on the leptospirosis antibody test.

    Prescriber still continue the treatment with 2g of ceftriaxone

    Recommendation

    Suggest to reduce the dose of ceftriaxone to 1g od.

    Outcome and monitoring parameters.

    Prescriber still continued the ceftriaxone 2g od.